drugset / Trial / NCT00003665
Vaccine Therapy in Treating Patients With Stage IV Melanoma
RandomizedParallel-groupOpen-labelTreatment
Summary
Randomized phase I trial to study the effectiveness of vaccine therapy in treating patients who have stage IV melanoma. Vaccines may make the body build an immune response to kill tumor cells.
Timeline
- Start
- 1999-04
- Primary completion
- 2002-10
- Completion
- 2002-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | dendritic cell-MART-1 peptide vaccine | Vaccine | — | Intravenous |
| Background | Tumor Infiltrating Lymphocytes | Cell therapy | — | — |
| Background | gp100 antigen | Peptide | — | — |
| Background | tyrosinase peptide | Peptide | — | — |